Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) EBT Margin (2016 - 2025)

Historic EBT Margin for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to 20.75%.

  • Collegium Pharmaceutical's EBT Margin rose 109700.0% to 20.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.68%, marking a year-over-year decrease of 106800.0%. This contributed to the annual value of 15.61% for FY2024, which is 22500.0% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its EBT Margin stood at 20.75% for Q3 2025, which was up 109700.0% from 9.06% recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's EBT Margin registered a high of 31.19% during Q4 2023, and its lowest value of 142.08% during Q4 2021.
  • Its 5-year average for EBT Margin is 1.08%, with a median of 9.78% in 2024.
  • Per our database at Business Quant, Collegium Pharmaceutical's EBT Margin crashed by -1516000bps in 2021 and then skyrocketed by 1360700bps in 2022.
  • Over the past 5 years, Collegium Pharmaceutical's EBT Margin (Quarter) stood at 142.08% in 2021, then surged by 96bps to 6.01% in 2022, then soared by 619bps to 31.19% in 2023, then plummeted by -70bps to 9.49% in 2024, then soared by 119bps to 20.75% in 2025.
  • Its EBT Margin stands at 20.75% for Q3 2025, versus 9.06% for Q2 2025 and 1.76% for Q1 2025.